Complete Lymph Node Dissection for Regional Nodal Metastasis

Clinics in Plastic Surgery

Volumn 37, Issue 1, 2010, Pages 113-125

  Dzwierzynski, William W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Axillary dissection; Complete lymph node dissection; Groin dissection; Ilioinguinal dissection; Lymphedema; Therapeutic lymph node dissection

Indexed keywords

AXILLARY LYMPH NODE; CANCER RECURRENCE; CLINICAL TRIAL; HEMATOMA; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; NERVE INJURY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; RISK REDUCTION; SENTINEL LYMPH NODE BIOPSY; SEROMA; SKIN INFECTION; SKIN NECROSIS; STANDARDIZATION; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

AXILLA; GROIN; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 70449491888     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2009.07.002     Document Type: Review

References (61)

1. Bilimoria K.Y., Balch C.M., Bentrem D.J., et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 15 6 (2008) 1566-1576
2. Neuhaus S.J., Clark M.A., Thomas J.M., et al. Dr Herbert Lumley Snow, MD, MRCS (1847-1930): the original champion of elective lymph node dissection in melanoma. Ann Surg Oncol 11 9 (2004) 875-878
3. van Akkooi A.C.J., Bouwhuis M.G., van Geel A.N., et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 33 (2007) 102-108
4. Sim F.H., Taylor W.F., Ivins J.C., et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in the management of malignant melanoma: preliminary results. Cancer 41 (1978) 948-956
5. Veronesi U., Adamus J., Bandiera D.C., et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 297 (1977) 627-630
6. Karakousis C.P. Therapeutic lymph node dissection and malignant melanoma. Semin Surg Oncol 14 (1998) 291-301
7. Morton D.L. John Wayne Cancer Institute. A clinical study of wide excision alone versus wide excision with intraoperative lymphatic mapping and selective lymph node dissection in the treatment of patients with cutaneous invasive melanoma. Available at: (2009). http://clinicaltrials.gov/ct2/show/NCT00275496?intr=%22Complete+Lymph+No de+Dissection%22&rank=1 Accessed April 30, 2009
8. Morton D.L., Thompson J.F., Cochran A.J., et al. Selective lymphadenectomy trial group. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. J Clin Oncol 23 (2005) 7500-7710
9. Practice guidelines in oncology vol. 2 (2009), National Comprehensive Cancer Network-Melanoma. http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf Accessed January 21, 2009
10. Cormier J.N., Xing Y., Ding M., et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 23 25 (2005) 6054-6062
11. Haddad F.F., Stall A., Messina J., et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 6 2 (1999) 144-149
12. Wagner J.D., Corbett L., Park H.M., et al. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg 105 6 (2000) 1956-1966
13. Pu L.L.Q., Cruse C.W., Wells K.E., et al. Superficial femoral lymph node dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity. Ann Plast Surg 51 1 (2003) 69-76
14. Page A.J., Carlson G.W., Delman K.A., et al. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg 73 7 (2007) 674-678 [discussion: 678-9]
15. Satzger I., Völker B., Meier A., et al. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes. Ann Surg Oncol 15 6 (2008) 1723-1732
16. Guggenheim M., Dummer R., Jung F.J., et al. The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma - a retrospective analysis of 392 cases. Br J Cancer 98 (2008) 1922-1928
17. Nowecki Z.I., Rutkowski P., Michej W., et al. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm. Ann Surg Oncol 15 8 (2008) 2223-2234
18. Wagner J.D., Gordon M.S., Chuang T.Y., et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 89 2 (2005) 453-462
19. Wagner J.D., Davidson D., Coleman III J.J., et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 6 4 (1999) 398-404
20. Gershenwald J.E., Andtbacka R.H.I., Prieto V.G., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 26 26 (2008) 4296-4303
21. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 10 5 (2003) 575-581
22. Frankel T.L., Griffith K.A., Lowe L., et al. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?. Ann Surg Oncol 15 9 (2008) 2403-2411
23. Mack L.A., and McKinnon J.G. Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol 86 (2004) 189-199
24. Karakousis C.P. Surgical procedures and lymphedema of the upper and lower extremity. J Surg Oncol 93 (2006) 87-91
25. Karakousis C.P. Therapeutic node dissection in malignant melanoma. Ann Surg Oncol 5 6 (1998) 473-482
26. Allan C.P., Hayes A.J., Thomas J.M., et al. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. ANZ J Surg 78 (2008) 982-986
27. van der Ploeg I.M., Valdes olmos R.A., Kroon B.B., et al. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?. Ann Surg Oncol 15 5 (2008) 1485-1491
28. Karakousis C.P., and Driscoll D.L. Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg 171 (1996) 421-422
29. Santinami M., Carbone A., Crippa F., et al. Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes. Melanoma Res 19 2 (2009) 112-118
30. Sabel M.S., Griffith K.A., Arora A., et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery 141 6 (2007) 728-735
31. Pearlman N.W., Robinson W.A., Dreeiling L.K., et al. Modified ilioinguinal node dissection for metastatic melanoma. Am J Surg 170 (1995) 647-650
32. Schmeider C., Brodersen J.P., Scheuerlein H., et al. Combined endoscopic and open inguinal dissection for malignant melanoma. Arch Surg 388 (2003) 42-47
33. McMasters K.M., Chao C., Wong S.L., et al. Interval sentinel lymph nodes in melanoma. Arch Surg 137 (2002) 543-549
34. Karakousis C.P. The technique of popliteal node dissection. Surg Gynecol Obstet 151 (1980) 420-423
35. Sholar A., Martin R.C., and McMasters K.M. Popliteal lymph node dissection. Ann Surg Oncol 12 (2005) 189-193
36. Matter M., Lalonde M.N., Allaoua M., et al. The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients. J Nucl Med 48 10 (2007) 1607-1613
37. Spillane A.J., Cheung B.L., Stretch J.R., et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg 249 3 (2009) 473-480
38. Chan A.D., Essner R., Wanek L.A., et al. Judging the therapeutic value of lymph node dissections for melanoma. J Am Coll Surg 191 1 (2000) 16-22
39. Serpell J.W., Carne P.W.G., Bailey M., et al. Radical lymph node dissection for melanoma. ANZ J Surg 73 (2003) 294-299
40. Kretschmer L., Thomas K.M., Peeters S., et al. Postoperative morbidity of lymph node excision for cutaneous melanoma - sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res 18 1 (2008) 16-21
41. Neuss H., Raue W., Koplin G., et al. Intraoperative application of fibrin sealant does not reduce the duration of closed suction drainage following radical axillary lymph node dissection in melanoma patients: a prospective randomized trial in 58 patients. World J Surg 32 (2008) 1450-1455
42. Guggenheim M.M., Hug U., Jung F.J., et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg 247 4 (2008) 687-693
43. Poos H.P., Kruijff S., Bastiaannet E., et al. Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol 35 8 (2009) 877-883
44. Tonouchi H., Ohmori Y., Kobayashi M., et al. Operative morbidity associated with groin dissections. Surg Today 34 (2004) 413-418
45. Beitsch P., and Balch C. Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 164 5 (1992) 462-465 [discussion: 465-6]
46. Karakousis C.P., and Driscoll D.L. Groin dissection in malignant melanoma. Br J Surg 81 12 (1994) 1771-1774
47. deVries M., Vonkeman W.G., van Ginkel R.J., et al. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol 32 (2006) 785-789
48. Spillane A.J., Saw R.P., Tucker M., et al. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg 248 2 (2008) 286-293
49. Starritt E.C., Joseph D., McKinnon J.G., et al. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg 240 5 (2004) 866-874
50. Erba P., Wettstein R., Rieger U.M., et al. A study of the effect of sartorius transposition on lymph node flow after ilioinguinal node dissection. Ann Plast Surg 61 3 (2008) 310-313
51. Calabro A., Singletary S.E., Balch C.M., et al. Patterns of relapse of 1001 consecutive patients with melanoma nodal metastases. Arch Surg 124 9 (1989) 1051-1055
52. Karakousis C.P., Hena M.A., Emrich L.J., et al. Axillary node dissection in malignant melanoma: results and complications. Surgery 108 1 (1990) 10-17
53. Gadd M.A., and Coit D.G. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 127 (1992) 1412-1416
54. Kretschmer L., Preuer K.-P.B., Neumann C., et al. Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: risk factors and prognostic impact. Melanoma Res 12 5 (2002) 499-504
55. Lawton G., Rasque H., Arivan S., et al. Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma. J Am Coll Surg 195 3 (2002) 339-351
56. Nathansohn N., Schachter J., Gutman H., et al. Patterns of recurrence in patients with melanoma after radical lymph node dissection. Arch Surg 140 (2005) 1172-1177
57. Singletary S.E., Shallenberger R., Guinee V.F., et al. Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet 174 3 (1992) 195-200
58. Karakousis C.P., and Driscoll D.L. Prognostic parameters in localized melanoma: gender versus anatomical location. Eur J Cancer 31 3 (1995) 320-324
59. Hughes T.M., A'Hern R.P., Thomas J.M., et al. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 87 7 (2000) 892-901
60. Ranieri J.M., Wagner J.E., Azuaje R., et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 9 10 (2002) 975-981
61. Meyer T., Merkel S., Gohl J., et al. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol 28 (2002) 424-430